Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread

Breast Cancer Research and Treatment

Volumn 82, Issue 1, 2003, Pages 29-37

  Gerber, Bernd ^a   Seitz, Eva ^b   Müller, Heiner ^b   Krause, Annette ^a   Reimer, Toralf ^b   Kundt, Günther ^b   Friese, Klaus ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Breast cancer; Costs; Metastatic disease; Staging; Treatment

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BONE SCINTISCANNING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DISTRESS SYNDROME; FEMALE; HEALTH CARE COST; HUMAN; LIVER; MAJOR CLINICAL STUDY; METASTASIS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; TREATMENT INDICATION; TUMOR VOLUME; ULTRASOUND;

BONE NEOPLASMS; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MASS SCREENING; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER;

EID: 0345688768     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000003917.05413.ac     Document Type: Article

References (35)

1. Brenner H, Hakulinen T: Long-term cancer patient survival achieved by the end of the 20th century: most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 85: 367-371, 2001
2. Niu Y, Fu X, Lv A, Fan Y, Wang Y: Potential markers predicting distant metastasis in axillary node-negative breast carcinoma. Int J Cancer 98: 754-760, 2002
3. Barry MC, Thornton F, Murphy M, Younis F, Watson RG: The value of metastatic screening in early primary breast cancer. Ir J Med Sci 168: 248-250, 1999
4. Samant R, Ganguly P: Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. Arch Surg 134: 551-553, 1999
5. Ravaioli A, Tassinari D, Pasini G, Polselli A, Papi M, Fattori PP, Pasquini E, Masi A, Alessandrini F, Canuti D, Panzini I, Drudi G: Staging of breast cancer: what standards should be used in research and clinical practice? Ann Oncol 9: 1173-1177, 1998
6. Myers RE, Johnston M, Pritchard K, Levine M, Oliver T: Baseline staging tests in primary breast cancer: a practice guideline. CMAJ 164: 1439-1444, 2001
7. Ravaioli A, Pasini G, Polselli A, Papi M, Tassinari D, Arcangeli V, Milandri C, Amadori D, Bravi M, Rossi D, Fattori PP, Pasquini E, Panzini I: Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat 72: 53-60, 2002
8. Dillman RO, Chico S: Radiologic tests after a new diagnosis of breast cancer. Eff Clin Pract 3: 1-6, 2000
9. Sakorafas GH, Tsiotou AG, Pavlakis G: Follow-up after primary treatment for breast cancer. Acta Oncol 39: 935-940, 2000
10. Donnelly J, Mack P, Donaldson LA: Follow-up of breast cancer: time for a new approach? Int J Clin Pract 55: 431-433, 2001
11. Tassinari D, Sartori S, Ravaioli A: Staging of breast cancer. Is the evidence so evident? Ann Oncol 12: 1653, D, 2001
12. Will BP, Berthelot JM, Le Petit C, Tomiak EM, Verma S, Evans WK: Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer 36: 724-735, 2000
13. Kaplan E, Meier P: Nonparametric estimation from incomplete observation. Am Stat Assoc 53: 457-481, 1987
14. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1963
15. Norum J, Andreassen T: Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective? Anticancer Res 20: 2193-2196, 2000
16. Ravaioli A, Tassinari D, Panzini I, Milandri C, Amadori D: Staging of breast cancer: it is time to break with tradition and initiate the evidence-based-medicine age. J Clin Oncol 19: 1234, 2001
17. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ, Edwards BK: Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91: 675-690, 1999
18. Vacek PM, Geller BM, Weaver DL, Foster RSJ: Increased mammography use and its impact on earlier breast cancer detection in Vermont, 1975-1999. Cancer 94: 2160-2168, 2002
19. Klemi PJ, Joensuu H, Toikkanen S, Tuominen J, Rasanen O, Tyrkko J, Parvinen I: Aggressiveness of breast cancers found with and without screening. BMJ 304: 467-469, 1992
20. ESMO: ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol 12: 1047-1048, 2001
21. Sant M: Differences in stage and therapy for breast cancer across Europe. Int J Cancer 93: 894-901, 2001
22. Hoffken K: The European experience. J Clin Oncol 19: 1125-1175, 2001
23. Curigliano G, Ferretti G, Colleoni M, Marrocco E, Peruzzotti G, De Cicco C, Paganelli G, Goldhirsch A: Bone scan had no role in the staging of 765 consecutive operable T(1-2)N(0-1) breast cancer patients without skeletal symptoms. Ann Oncol 12: 724-725, 2001
24. Hadley D, Fowble B, Torosian MH: Evidence for selective use of bone scans in early stage breast cancer. Oncol Rep 5: 991-993, 1998
25. Chen EA, Carlson GA, Coughlin BF, Reed WPJ, Garb JL, Frank JL: Routine chest roentgenography is unnecessary in the work-up of stage I and II breast cancer. J Clin Oncol 18: 3503-3506, 2000
26. Cooke AL: Baseline staging tests for breast cancer. CMAJ 166: 419, 2002
27. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ: Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21, 3357-3365, 2003
28. NIH: National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst Monogr 5-15, 2001
29. Nabholtz J, Pienkowski T, Mackey J, Pawlicki M, Guastalla JP, Vogel C, Weaver C, Walley M: Phase III trial comparing TAC (docetaxel, doxorubicin, cyclophosphamide) with FAC (5-fluorouracil, doxorubicin, cyclophosphamide) in the adjuvant treatment of node poitive breast cancer patients: interim analysis of the BCIRG 001study. Proc ASCO 21: 36a, #141, 2002
30. Rojas MP, Telaro E, Russo A, Fossati R, Confalonieri C, Liberati A: Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev CD001768, 2000
31. GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 271: 1587-1592, 1994
32. Rosselli DT, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271: 1593-1597, 1994
33. Palli D, Russo A, Saieva C, Ciatto S, Rosselli DT, Distante V, Pacini P: Intensive v.s. clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Follow-up. JAMA 281: 1586, 1999
34. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI, Clark G, Edge SB, Hayes DF, Hughes LL, Hutter RV, Morrow M, Page DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greene FL: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20: 3628-3636, 2002
35. Bruneton JN, Balu-Maestro C, Raffaelli C, Mourou MY, Cambon P, Granon C: Indications for hepatic ultrasonography in breast cancer staging and follow-up. Breast Cancer Res Treat 37: 115-121, 1996